Patents
Patents for C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
01/2010
01/19/2010CA2239904C Inhibitors of interleukin-1.beta. converting enzyme
01/14/2010WO2010004837A1 Therapeutic agent for amyotrophic lateral sclerosis
01/14/2010WO2010004394A1 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
01/14/2010CA2727820A1 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
01/14/2010CA2727282A1 Novel pyrrolidine derivatives as metap-2 inhibitors
01/12/2010US7645763 dipeptidylpeptidase-IV inhibitors; antidiabetic agents, antiarthritic agents, obesity, allograft transplantation, and osteoporosis caused by calcitonin; 1,3-disubstituted-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)-xanthine compounds
01/12/2010US7645758 (4-Methyl-piperazin-1-yl)-(6H-thieno[2,3-b]pyrrol-5-yl)-methanone; (2,3-Dichloro-6H-thieno[2,3-b]pyrrol-5-yl)-(4-methyl-piperazin-1-yl)-methanone; histamine H4 receptor antagonist; treats allergic rhinitis
01/12/2010CA2399818C Preventive and therapeutic medicament for gastroesophageal reflux disease
01/07/2010US20100004463 Process for synthesizing carbapenem using raney nickel
01/06/2010EP2139334A1 2-cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
01/06/2010EP1885364B1 Halogenated quindoline dimers for the treatment of cancer
01/05/2010US7642362 Compounds as semaphorin inhibitors
01/05/2010US7642229 Synergistic antineoplastic effect; side effect reduction
01/05/2010CA2318192C .beta.2-adrenergic receptor agonists
12/2009
12/31/2009US20090326221 New oxabispidine compunds useful in the treatment of cardiac arrhythmias
12/31/2009US20090326218 Azepinoindole and Pyridoindole Derivatives as Pharmaceutical Agents
12/31/2009US20090324625 Heterocyclic Aromatic Compounds Useful As Growth Hormone Secretagogues
12/30/2009WO2009158396A1 Diketopiperidine derivatives as hiv attachment inhibitors
12/30/2009WO2009158394A1 Diketo azolopiperidines and azolopiperazines as anti-hiv agents
12/30/2009WO2009156863A2 Substituted tricyclic derivatives
12/30/2009EP2138498A1 Substituted tricyclic derivatives against neurodegenerative diseases
12/30/2009EP2137196A1 Tricyclic nitrogen containing compounds as antibacterial agents
12/30/2009EP1562949B1 Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
12/30/2009CA2728728A1 Substituted tricyclic derivatives
12/29/2009CA2563761C Inhibitors of the hiv integrase enzyme
12/23/2009WO2009155017A2 Novel substituted azabenzoxazoles
12/23/2009WO2009154132A1 Spirodiamine-diarylketoxime derivative
12/23/2009WO2009153025A1 Process for the preparation of bisindole alkaloid derivatives
12/23/2009WO2009152712A1 Vinflunine salts, preparation process and pharmaceutical composition thereof
12/23/2009EP2135872A1 Process for the preparation of bisindole alkaloid derivatives
12/23/2009EP2134343A2 Pyrrolo-pyridine kinase modulators
12/23/2009EP2134342A2 Monocyclic anilide spirolactam cgrp receptor antagonists
12/23/2009EP1879901B1 Pyrrolobenzodiazepines
12/23/2009CN101611041A Fused heterocyclic compound
12/23/2009CN101607968A Vinflunine salt, preparation method and pharmaceutical composition thereof
12/23/2009CN101607958A Quinazoline compounds
12/23/2009CA2727914A1 Spirodiamine-diaryl ketoxime derivative technical field
12/23/2009CA2725940A1 Novel substituted azabenzoxazoles
12/23/2009CA2724449A1 5-ht3 receptor modulators, methods of making, and use thereof
12/17/2009WO2009152200A1 Tricyclic indole derivatives and methods of use thereof
12/17/2009WO2009152072A1 Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents
12/17/2009WO2009150230A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009US20090312334 Immunomodulating Heterocyclic Compounds
12/17/2009CA2727680A1 2,4'-bipyridinyl compounds as protein kinase d inhibitors useful for the treatment of ia heart failure and cancer
12/17/2009CA2727620A1 Tricyclic indole derivatives and methods of use thereof
12/17/2009CA2727315A1 Pyrrolo [2, 3-c] pyridine derivatives as p38 kinase inhibiting agents
12/16/2009CN100569772C Azaindoles useful as inhibitors of JAK and other protein kinases
12/10/2009WO2009148062A1 Polycyclic compound and organic electroluminescent device using the same
12/09/2009CN100567293C N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
12/08/2009US7629338 for treating migraine, headaches; N-[(4S)-3-Methyl-2,5-dioxo-1',3'-dihydrospiro[imidazolidine-4,2'-inden]-5'-yl]-2-((6+-)-2-oxo-6-phenylpiperidin-1-yl)acetamide
12/08/2009CA2361525C Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
12/03/2009WO2009091856A3 Beta-lactamase inhibitors
12/03/2009WO2009077741A3 3-substituted-4-0x0-3, 4-dihydro-imidazo- [5, 1-d] [1,2,3,5] -tetrazine-8-carboxylic acid amides as anticancer agents
12/03/2009US20090299060 Compounds and methods for inhibiting mitotic progression
12/02/2009EP2128163A1 Spiro-ring compound
12/02/2009EP2124560A1 2-aminopyrimidine modulators of the histamine h4 receptor
12/02/2009EP1633759B1 Cross-linked glycopeptide-cephalosporin antibiotics
12/02/2009CN101595110A 7-substituted purine derivatives for immunosuppression
12/02/2009CN101591348A Tetrahydrochysene carboline acyl aminoacid benzyl ester, preparation method and application thereof
12/01/2009US7626032 4-Amino-3,3-dimethylpiperidine; reduced toxicity, and improved pharmacology and pharmacokinetics
12/01/2009US7625901 for treating migraine, headaches; 2-[(8S)-8-(3,5-Difluorophenyl)-6-oxo-7-azaspiro[4.5]dec-7-yl]-N-(2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridin]-2-yl)acetamide
12/01/2009US7625892 Pharmaceutical compositions for the treatment of diseases related to neurotrophines
11/2009
11/26/2009WO2009141288A2 Switchable special effect substances
11/26/2009CA2724842A1 Imidazo[1,2-a]pyridine compounds
11/25/2009EP2123654A1 Pyrazolopyrimidine compound
11/25/2009EP2120951A1 Inhibitors of akt activity
11/25/2009EP2120929A1 Use of inhibitors of the degradation of p27, in particular argyrin and derivatives thereof, for the treatment of proliferative diseases
11/24/2009US7622481 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
11/24/2009US7622476 1-allyl-( 5R,8S,10R)-terguride; antagonistic properties to 5-HT2 receptors for the prevention of migraine-related headache, Parkinson's disease, disorders of the thrombocyte function
11/19/2009WO2009140101A2 Imidazopyridine compounds useful as mmp-13 inhibitors
11/19/2009CA2722056A1 Hcv protease inhibitors
11/18/2009EP2119720A1 Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives
11/18/2009EP2118110A1 Cyclopropyl fused indolobenzazepine hcv inhibitors
11/18/2009CN101583622A Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
11/18/2009CN101580535A Hcv protease inhibitors
11/18/2009CN100560585C New benzimidazole derivative
11/17/2009US7618959 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli
11/17/2009CA2521950C Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
11/17/2009CA2407094C Diazabicyclic central nervous system active agents
11/17/2009CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors
11/12/2009WO2009136596A1 Organic electroluminescent element
11/12/2009WO2009135927A1 Substituted n-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
11/12/2009WO2009135925A1 Substituted n-imidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-ht6 ligands
11/12/2009WO2009135885A1 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/12/2009US20090280192 Method for treating or preventing alzheimer's disease
11/12/2009CA2723745A1 Fused pyrazine compounds useful for the treatment of degenerative and inflammatory diseases
11/11/2009EP2116547A1 Substituted N-imidazo(2, 1-b) thiazole-5-sulfonamide derivatives as 5-TH6 ligands
11/11/2009EP2116546A1 Substituted N-phenyl-2,3-dihydroimidazo[2,1-b]thiazole-5-sulfonamide derivatives as 5-HT6 ligands
11/11/2009EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009EP1313734B1 Aza heterocyclic derivatives and their therapeutic use
11/11/2009CN100558728C Calcitonin gene related peptide receptor antagonists
11/10/2009US7615639 8-Methoxy-5-methyl-1-(6-methyl-pyridin-3-yl)-2-oxo-2,5-dihydro-1H-pyrido[3,2-b]indole-3-carbonitrile, for treating HIV, viral infection; effective treating mutant HIV viruses which has drug resistance against currently available reverse transcriptase inhibitors
11/10/2009CA2481482C Tropane derivatives as ccr5 modulators
11/05/2009WO2009134726A1 Substituted pyrimidine derivatives as histamine h4 receptor ligands
11/05/2009WO2009104147A3 Azatricyclic antibiotic compounds
11/04/2009EP1481077B1 Mitotic kinesin inhibitors
11/04/2009EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009CN101573365A Compounds useful as protein kinase inhibitors
11/03/2009US7612094 Tri-substituted heteroaryls and methods of making and using the same
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
1 ... 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 ... 111